{"id":"W2526894720","doi":"10.1007/s12012-016-9386-7","title":"The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with Specificity","year":2016,"lang":"en","type":"article","venue":"Cardiovascular Toxicology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Nilotinib; Dasatinib; Tyrosine kinase; Ponatinib; Tyrosine-kinase inhibitor; Imatinib; Imatinib mesylate; Cardiac myocyte; Myocyte; Pharmacology; Chronic myelogenous leukemia; Chemistry; Cancer research; Biology; Leukemia; Internal medicine; Cell biology; Medicine; Signal transduction; Biochemistry; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003485891,0.0004011574,0.0003352677,0.0003447769,0.0001974588,0.0003345056,0.0001787892,0.0003650853,0.004561331],"category_scores_gemma":[0.0003874241,0.0001874926,0.0002648202,0.0001770023,0.0002173443,0.0003365137,0.0002900112,0.0009920435,0.0009748575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002273445,"about_ca_system_score_gemma":0.000277469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003632171,"about_ca_topic_score_gemma":0.0008943915,"domain_scores_codex":[0.9997336,0.00006073071,0.0000175621,0.00004904825,0.00008298727,0.00005612336],"domain_scores_gemma":[0.9996217,0.0001109697,0.0001021813,0.00003939941,0.00006122055,0.00006444865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002178217,0.0000602834,0.0005020039,0.0001047729,0.00002487397,0.00005603084,0.00002231113,0.0001878742,0.9858435,0.0002908343,0.00023455,0.01245519],"study_design_scores_gemma":[0.00004232887,0.001866539,0.01727296,0.00002627798,0.00005532083,0.0005528564,0.00003640398,0.0004765965,0.9720961,0.0001972428,0.007368477,0.000008971433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9335135,0.02421004,0.01028865,0.0009721032,0.0001750075,0.0002002264,0.00123398,0.0003555669,0.02905086],"genre_scores_gemma":[0.9834455,0.005763661,0.00228112,0.0004180848,0.00004800129,0.00005944612,0.0004375335,0.00004569979,0.007501033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004561331,"threshold_uncertainty_score":0.01525921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004570088613258425,"score_gpt":0.1943314985870412,"score_spread":0.1897614099737828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}